IPRATROPIUM BROMIDE AND ALBUTEROL

IPRATROPIUM BROMIDE AND ALBUTEROL was reported 2765 times

IPRATROPIUM BROMIDE AND ALBUTEROL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMMONIA 2 0.0351
1 BLOOD CARBON MONOXIDE INCREASED 2 0.0247
2 BLOOD IMMUNOGLOBULIN E ABNORMAL 2 0.0220
3 BIOPSY LYMPH GLAND 2 0.0204
4 BLOOD IMMUNOGLOBULIN E DECREASED 3 0.0186
5 HYPERTROPHY OF TONGUE PAPILLAE 2 0.0165
6 PANCREATIC CALCIFICATION 2 0.0154
7 POST-TUSSIVE VOMITING 2 0.0123
8 DEPENDENCE ON OXYGEN THERAPY 6 0.0122
9 CHRONIC GASTROINTESTINAL BLEEDING 3 0.0118
10 LUMBAR HERNIA 2 0.0118
11 PRODUCT DELIVERY MECHANISM ISSUE 58 0.0108
12 BENDOPNOEA 2 0.0091
13 PHARYNGITIS BACTERIAL 2 0.0078
14 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 4 0.0076
15 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 3 0.0070
16 GASTROINTESTINAL ARTERIOVENOUS MALFORMATION 2 0.0068
17 BRONCHOSPASM PARADOXICAL 2 0.0066
18 ALLERGY TO PLANTS 3 0.0066
19 INCISION SITE ERYTHEMA 3 0.0065
20 LIPOEDEMA 2 0.0051
21 INFUSION SITE MASS 5 0.0046
22 INFUSION SITE DISCOLOURATION 4 0.0045
23 BRONCHIAL WALL THICKENING 3 0.0042
24 FORCED EXPIRATORY VOLUME DECREASED 11 0.0039
25 ALLERGIC SINUSITIS 3 0.0035
26 INFUSION SITE DISCHARGE 6 0.0034
27 DEVICE MAINTENANCE ISSUE 2 0.0034
28 DIAPHRAGMATIC PARALYSIS 2 0.0033
29 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 2 0.0032
30 TONGUE INJURY 3 0.0032
31 INTERMITTENT CLAUDICATION 5 0.0032
32 DUST ALLERGY 3 0.0031
33 MITE ALLERGY 2 0.0031
34 BLOOD IMMUNOGLOBULIN M DECREASED 3 0.0030
35 SEASONAL ALLERGY 42 0.0030
36 HEAT ILLNESS 2 0.0030
37 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 16 0.0029
38 CARBON DIOXIDE INCREASED 4 0.0029
39 BLOOD IMMUNOGLOBULIN E INCREASED 7 0.0029
40 INFUSION SITE PRURITUS 9 0.0028
41 ALLERGY TO ANIMAL 3 0.0028
42 DEVICE INEFFECTIVE 3 0.0028
43 CERVICAL RADICULOPATHY 2 0.0028
44 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
45 PNEUMONIA STREPTOCOCCAL 3 0.0027
46 PRECANCEROUS SKIN LESION 4 0.0027
47 BRONCHIAL DISORDER 4 0.0026
48 PNEUMONIA INFLUENZAL 3 0.0025
49 CHRONIC RESPIRATORY FAILURE 3 0.0025
50 POST-TRAUMATIC NECK SYNDROME 2 0.0025
51 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 2 0.0024
52 GASTRIC ULCER PERFORATION 3 0.0024
53 PERIORBITAL PAIN 2 0.0024
54 CRANIOFACIAL FRACTURE 2 0.0023
55 CERVICAL SPINAL STENOSIS 4 0.0023
56 MULTIPLE ALLERGIES 18 0.0023
57 HILAR LYMPHADENOPATHY 2 0.0023
58 ABDOMINAL SEPSIS 2 0.0023
59 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 2 0.0022
60 ESSENTIAL HYPERTENSION 4 0.0022
61 PERIPHERAL ARTERY OCCLUSION 3 0.0021
62 INFUSION SITE NODULE 2 0.0021
63 VOCAL CORD DISORDER 4 0.0020
64 HYPERPARATHYROIDISM SECONDARY 5 0.0020
65 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 104 0.0020
66 HYPERCAPNIA 6 0.0020
67 PNEUMONIA PSEUDOMONAL 3 0.0020
68 NASAL INFLAMMATION 2 0.0019
69 EYE CONTUSION 4 0.0019
70 BONE DEMINERALISATION 2 0.0019
71 TOTAL LUNG CAPACITY DECREASED 3 0.0019
72 AORTIC VALVE DISEASE 3 0.0019
73 INFUSION SITE BRUISING 4 0.0019
74 SPUTUM INCREASED 4 0.0018
75 CLAUSTROPHOBIA 2 0.0018
76 OXYGEN THERAPY 3 0.0018
77 INFUSION SITE HAEMORRHAGE 6 0.0018
78 IDIOPATHIC INTRACRANIAL HYPERTENSION 4 0.0018
79 HALO VISION 2 0.0018
80 LOWER RESPIRATORY TRACT CONGESTION 3 0.0018
81 CARBON DIOXIDE DECREASED 2 0.0017
82 OXYGEN CONSUMPTION INCREASED 4 0.0017
83 NASAL POLYPS 8 0.0016
84 DEVICE INFUSION ISSUE 4 0.0016
85 MALLORY-WEISS SYNDROME 2 0.0016
86 BRONCHIAL SECRETION RETENTION 2 0.0016
87 APPLICATION SITE WARMTH 2 0.0016
88 NOCTURNAL DYSPNOEA 2 0.0016
89 SKIN ABRASION 7 0.0015
90 SPUTUM DISCOLOURED 14 0.0015
91 ORAL FUNGAL INFECTION 4 0.0015
92 CHEST INJURY 3 0.0014
93 WHEEZING 85 0.0014
94 PERIPHERAL ARTERY THROMBOSIS 2 0.0014
95 DRUG TOLERANCE DECREASED 4 0.0014
96 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
97 BREATH SOUNDS ABNORMAL 7 0.0014
98 CATAPLEXY 2 0.0014
99 PULMONARY MASS 21 0.0014
100 OXYGEN SATURATION ABNORMAL 4 0.0014
101 INFUSION SITE PAIN 18 0.0014
102 LUNG CANCER METASTATIC 4 0.0014
103 NOROVIRUS INFECTION 2 0.0014
104 PULMONARY FUNCTION TEST DECREASED 6 0.0014
105 PULMONARY PAIN 4 0.0014
106 LUMBAR SPINAL STENOSIS 4 0.0014
107 LIMB MASS 3 0.0014
108 MIDDLE EAR EFFUSION 3 0.0014
109 INFUSION SITE INDURATION 2 0.0013
110 APRAXIA 2 0.0013
111 SINUS CONGESTION 18 0.0013
112 PARANASAL SINUS HYPERSECRETION 5 0.0013
113 RESPIRATORY TRACT INFECTION VIRAL 3 0.0013
114 SECRETION DISCHARGE 16 0.0013
115 INFUSION SITE SWELLING 8 0.0013
116 INSURANCE ISSUE 19 0.0012
117 BRONCHITIS CHRONIC 3 0.0012
118 PHARYNGEAL SWELLING 12 0.0012
119 MEAN CELL HAEMOGLOBIN INCREASED 2 0.0012
120 MEDICAL PROCEDURE 2 0.0012
121 EMPHYSEMA 12 0.0012
122 INFUSION SITE ERYTHEMA 10 0.0012
123 CANDIDA INFECTION 20 0.0012
124 ACUTE SINUSITIS 2 0.0012
125 CATHETER SITE PAIN 3 0.0012
126 HERNIA REPAIR 3 0.0012
127 AORTIC STENOSIS 4 0.0011
128 INTENTIONAL DEVICE MISUSE 5 0.0011
129 INFUSION SITE EXTRAVASATION 7 0.0011
130 RHINITIS ALLERGIC 5 0.0011
131 RHINITIS 9 0.0011
132 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
133 EAR DISORDER 5 0.0011
134 CYSTIC FIBROSIS 6 0.0011
135 NEPHROGENIC ANAEMIA 5 0.0011
136 ASTHMA 119 0.0011
137 SARCOIDOSIS 5 0.0011
138 DERMATITIS CONTACT 12 0.0011
139 AORTIC ANEURYSM 8 0.0011
140 PSEUDOMONAS INFECTION 9 0.0010
141 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
142 GINGIVAL DISORDER 4 0.0010
143 BRONCHIECTASIS 7 0.0010
144 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
145 COVID-19 PNEUMONIA 12 0.0010
146 RESPIRATION ABNORMAL 7 0.0010
147 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
148 PNEUMONIA FUNGAL 4 0.0010
149 HYPERVOLAEMIA 5 0.0010
150 DIPLEGIA 2 0.0010
151 EMPYEMA 2 0.0010
152 FORMICATION 7 0.0010
153 ANEURYSM 5 0.0010
154 RESPIRATORY TRACT INFECTION 26 0.0010
155 DEVICE RELATED SEPSIS 2 0.0010
156 EAR HAEMORRHAGE 2 0.0010
157 ACUTE RESPIRATORY FAILURE 19 0.0010
158 PULMONARY CONGESTION 13 0.0010
159 PRODUCTIVE COUGH 47 0.0010
160 INTENTIONAL PRODUCT USE ISSUE 85 0.0010
161 RESPIRATORY TRACT CONGESTION 15 0.0009
162 SLEEP APNOEA SYNDROME 18 0.0009
163 DYSPNOEA EXERTIONAL 35 0.0009
164 HYPOVENTILATION 3 0.0009
165 GASTRIC BYPASS 2 0.0009
166 ASPERGILLUS INFECTION 6 0.0009
167 COLONOSCOPY 2 0.0009
168 PEPTIC ULCER 3 0.0009
169 LARGE INTESTINAL OBSTRUCTION 2 0.0009
170 CORNEAL OEDEMA 2 0.0009
171 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
172 IRON DEFICIENCY 4 0.0009
173 PERIARTHRITIS 2 0.0009
174 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
175 BREAKTHROUGH PAIN 2 0.0009
176 INFUSION SITE INFECTION 2 0.0009
177 PATELLA FRACTURE 2 0.0009
178 PRODUCT PRESCRIBING ERROR 20 0.0008
179 LUNG DISORDER 40 0.0008
180 DERMAL CYST 2 0.0008
181 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
182 SKIN INFECTION 9 0.0008
183 CHRONIC SINUSITIS 3 0.0008
184 CATHETER SITE INFECTION 3 0.0008
185 DYSPNOEA 449 0.0008
186 PARANASAL SINUS DISCOMFORT 3 0.0008
187 LABYRINTHITIS 2 0.0008
188 FACE INJURY 3 0.0008
189 DERMATOMYOSITIS 2 0.0008
190 APPENDICITIS PERFORATED 2 0.0008
191 DRUG DELIVERY SYSTEM MALFUNCTION 4 0.0008
192 LACTOSE INTOLERANCE 2 0.0008
193 AORTIC ARTERIOSCLEROSIS 2 0.0008
194 REHABILITATION THERAPY 3 0.0008
195 END STAGE RENAL DISEASE 14 0.0008
196 PROSTATOMEGALY 3 0.0008
197 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
198 DECREASED ACTIVITY 8 0.0007
199 HIP SURGERY 4 0.0007
200 TRIGGER FINGER 3 0.0007
201 PULMONARY THROMBOSIS 8 0.0007
202 APPLICATION SITE HAEMORRHAGE 2 0.0007
203 PLEURITIC PAIN 2 0.0007
204 APHONIA 10 0.0007
205 BRONCHITIS 53 0.0007
206 CARPAL TUNNEL SYNDROME 10 0.0007
207 EAR INFECTION 19 0.0007
208 TONGUE DISCOMFORT 3 0.0007
209 INJECTION SITE SCAR 2 0.0007
210 SHOULDER OPERATION 3 0.0007
211 MIDDLE INSOMNIA 13 0.0007
212 SCIATICA 11 0.0007
213 SKIN WARM 4 0.0007
214 MAJOR DEPRESSION 5 0.0007
215 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
216 POST PROCEDURAL COMPLICATION 13 0.0007
217 ATYPICAL PNEUMONIA 2 0.0007
218 METABOLIC ENCEPHALOPATHY 2 0.0007
219 CENTRAL VENOUS CATHETERISATION 2 0.0007
220 JOINT INJURY 14 0.0007
221 PNEUMONIA BACTERIAL 6 0.0007
222 CHEST X-RAY ABNORMAL 2 0.0007
223 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
224 LOCALISED OEDEMA 3 0.0006
225 FOOD ALLERGY 5 0.0006
226 HAEMOPTYSIS 18 0.0006
227 INVESTIGATION 2 0.0006
228 RESPIRATORY DISORDER 19 0.0006
229 DEVICE DEFECTIVE 11 0.0006
230 BREAST CANCER RECURRENT 2 0.0006
231 VIRAL UPPER RESPIRATORY TRACT INFECTION 3 0.0006
232 PNEUMOTHORAX 10 0.0006
233 POLYMYALGIA RHEUMATICA 2 0.0006
234 GINGIVAL PAIN 5 0.0006
235 UPPER RESPIRATORY TRACT INFECTION 29 0.0006
236 PNEUMONIA VIRAL 2 0.0006
237 SUBCUTANEOUS ABSCESS 3 0.0006
238 PULMONARY FIBROSIS 12 0.0006
239 HYPOXIA 22 0.0006
240 OCULAR DISCOMFORT 7 0.0006
241 LOOSE TOOTH 2 0.0006
242 STENT PLACEMENT 5 0.0006
243 POLYURIA 5 0.0006
244 FLUID RETENTION 31 0.0006
245 LIGAMENT SPRAIN 6 0.0006
246 SINUS DISORDER 12 0.0006
247 OXYGEN SATURATION DECREASED 34 0.0006
248 EXPIRED DEVICE USED 2 0.0006
249 PNEUMONIA 195 0.0006
250 CARDIAC FAILURE ACUTE 4 0.0006
251 COUGH 168 0.0006
252 TERMINAL STATE 4 0.0006
253 SINUSITIS 61 0.0006
254 CHEST DISCOMFORT 60 0.0006
255 EAR DISCOMFORT 6 0.0006
256 INCREASED UPPER AIRWAY SECRETION 3 0.0006
257 OSTEOPOROSIS 24 0.0006
258 ECCHYMOSIS 4 0.0006
259 RIB FRACTURE 12 0.0006
260 PERIPHERAL VASCULAR DISORDER 3 0.0006
261 APLASIA PURE RED CELL 2 0.0006
262 MUSCULOSKELETAL DISCOMFORT 10 0.0006
263 POOR VENOUS ACCESS 6 0.0006
264 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
265 MUSCLE STRAIN 5 0.0006
266 GRANULOMA 2 0.0006
267 ORAL DISCOMFORT 8 0.0006
268 SENSITIVITY TO WEATHER CHANGE 3 0.0006
269 ERYTHEMA NODOSUM 2 0.0006
270 BRONCHIOLITIS 2 0.0006
271 LUNG TRANSPLANT 2 0.0006
272 PRODUCT CONTAMINATION 2 0.0006
273 OROPHARYNGEAL PAIN 52 0.0006
274 BODY HEIGHT DECREASED 6 0.0006
275 PRODUCT SUPPLY ISSUE 4 0.0006
276 COMPRESSION FRACTURE 3 0.0006
277 GOUT 10 0.0006
278 APPARENT DEATH 2 0.0006
279 SKIN LACERATION 6 0.0006
280 BACK INJURY 6 0.0006
281 WOUND INFECTION 6 0.0005
282 IRON DEFICIENCY ANAEMIA 5 0.0005
283 CHRONIC KIDNEY DISEASE 41 0.0005
284 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
285 ANGIOPATHY 3 0.0005
286 CHEMOTHERAPY 2 0.0005
287 ECONOMIC PROBLEM 8 0.0005
288 NASAL CONGESTION 31 0.0005
289 CARDIAC VALVE DISEASE 3 0.0005
290 CLAVICLE FRACTURE 2 0.0005
291 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
292 SKIN ATROPHY 3 0.0005
293 EXERCISE TOLERANCE DECREASED 3 0.0005
294 MOUTH SWELLING 3 0.0005
295 GLAUCOMA 10 0.0005
296 ATELECTASIS 5 0.0005
297 ATRIOVENTRICULAR BLOCK 4 0.0005
298 PRESCRIBED OVERDOSE 10 0.0005
299 ELECTROLYTE IMBALANCE 6 0.0005
300 DEVICE USE ISSUE 9 0.0005
301 VITAMIN D DEFICIENCY 5 0.0005
302 CHOKING 10 0.0005
303 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
304 VITREOUS FLOATERS 5 0.0005
305 HOSPICE CARE 5 0.0005
306 NASAL DISCOMFORT 4 0.0005
307 BLOOD ALBUMIN DECREASED 4 0.0005
308 BLOOD PRESSURE ABNORMAL 10 0.0005
309 OESOPHAGEAL CANDIDIASIS 2 0.0005
310 OBSTRUCTION 2 0.0005
311 WRIST FRACTURE 6 0.0005
312 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
313 FULL BLOOD COUNT DECREASED 10 0.0005
314 NEURALGIA 12 0.0005
315 SNEEZING 11 0.0005
316 PERIPHERAL VENOUS DISEASE 2 0.0005
317 CATARACT 29 0.0005
318 AORTIC DISSECTION 2 0.0005
319 TENDERNESS 5 0.0005
320 PETECHIAE 5 0.0005
321 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 23 0.0005
322 COVID-19 84 0.0005
323 LIMB INJURY 13 0.0005
324 WEIGHT FLUCTUATION 5 0.0005
325 TRANSFUSION 5 0.0005
326 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
327 FOOT FRACTURE 9 0.0005
328 HEAD INJURY 15 0.0005
329 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
330 FOREIGN BODY SENSATION IN EYES 3 0.0005
331 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
332 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
333 RETCHING 10 0.0005
334 ABNORMAL SENSATION IN EYE 2 0.0005
335 DEVICE OPERATIONAL ISSUE 2 0.0005
336 HYPOAESTHESIA ORAL 7 0.0005
337 CARDIAC MURMUR 4 0.0005
338 LUNG NEOPLASM MALIGNANT 19 0.0005
339 HORDEOLUM 2 0.0005
340 DYSPHONIA 27 0.0005
341 OSTEOPENIA 7 0.0005
342 IMMOBILE 2 0.0005
343 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
344 DIVERTICULUM INTESTINAL 2 0.0005
345 EYE DISORDER 15 0.0005
346 MELANOCYTIC NAEVUS 2 0.0005
347 ONYCHOMYCOSIS 2 0.0005
348 ORAL CANDIDIASIS 6 0.0005
349 NERVE INJURY 5 0.0004
350 ORAL PAIN 10 0.0004
351 OROPHARYNGEAL DISCOMFORT 4 0.0004
352 HEART RATE IRREGULAR 10 0.0004
353 PRODUCT LABEL ISSUE 3 0.0004
354 PRODUCT QUALITY ISSUE 60 0.0004
355 DEVICE DELIVERY SYSTEM ISSUE 12 0.0004
356 DISEASE COMPLICATION 2 0.0004
357 INCREASED TENDENCY TO BRUISE 4 0.0004
358 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
359 PERICARDIAL EFFUSION 10 0.0004
360 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
361 INTERCEPTED MEDICATION ERROR 2 0.0004
362 BLOOD POTASSIUM INCREASED 7 0.0004
363 PERFORMANCE STATUS DECREASED 2 0.0004
364 NEPHROPATHY 4 0.0004
365 SPINAL PAIN 5 0.0004
366 LACERATION 4 0.0004
367 LEUKAEMIA 4 0.0004
368 THERMAL BURN 3 0.0004
369 MACULAR DEGENERATION 5 0.0004
370 POOR QUALITY SLEEP 9 0.0004
371 ILLNESS 43 0.0004
372 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
373 HERNIA 8 0.0004
374 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
375 FIBROMYALGIA 10 0.0004
376 KIDNEY INFECTION 8 0.0004
377 SENSITIVE SKIN 3 0.0004
378 KNEE OPERATION 4 0.0004
379 PANCREATIC DISORDER 2 0.0004
380 FOOT OPERATION 2 0.0004
381 ORGANISING PNEUMONIA 2 0.0004
382 UPPER LIMB FRACTURE 8 0.0004
383 PNEUMONIA ASPIRATION 10 0.0004
384 SPINAL FRACTURE 8 0.0004
385 DEVICE MALFUNCTION 28 0.0004
386 DERMATITIS ALLERGIC 5 0.0004
387 DEMENTIA 11 0.0004
388 NEPHROLITHIASIS 18 0.0004
389 BOWEL MOVEMENT IRREGULARITY 3 0.0004
390 DEVICE RELATED INFECTION 6 0.0004
391 PAIN IN JAW 11 0.0004
392 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
393 RHINORRHOEA 25 0.0004
394 HIATUS HERNIA 5 0.0004
395 PULMONARY HYPERTENSION 8 0.0004
396 PRODUCT DOSE OMISSION 25 0.0004
397 FOOD CRAVING 2 0.0004
398 TOOTH INFECTION 5 0.0004
399 FURUNCLE 3 0.0004
400 FULL BLOOD COUNT ABNORMAL 4 0.0004
401 RENAL CYST 3 0.0004
402 CONJUNCTIVITIS 7 0.0004
403 INFLUENZA 42 0.0004
404 OBESITY 6 0.0004
405 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
406 LOCALISED INFECTION 9 0.0004
407 HYPOACUSIS 16 0.0004
408 EXTRA DOSE ADMINISTERED 15 0.0004
409 PRODUCT TASTE ABNORMAL 5 0.0004
410 BACK DISORDER 6 0.0004
411 DECUBITUS ULCER 3 0.0004
412 INTENTIONAL PRODUCT MISUSE 32 0.0004
413 HICCUPS 3 0.0004
414 ASTHENOPIA 2 0.0004
415 CONTUSION 35 0.0004
416 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
417 CHOKING SENSATION 2 0.0004
418 RESPIRATORY DISTRESS 10 0.0004
419 ACUTE CORONARY SYNDROME 3 0.0004
420 GASTRIC ULCER HAEMORRHAGE 2 0.0004
421 VIRAL INFECTION 12 0.0004
422 FUNGAL INFECTION 12 0.0004
423 HYPOMAGNESAEMIA 5 0.0004
424 NASOPHARYNGITIS 66 0.0004
425 URINARY TRACT INFECTION 61 0.0004
426 PULMONARY OEDEMA 16 0.0004
427 DEVICE ISSUE 32 0.0004
428 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
429 BLINDNESS UNILATERAL 5 0.0004
430 EYE INFECTION 4 0.0004
431 PRODUCT DOSE OMISSION ISSUE 104 0.0004
432 DIALYSIS 5 0.0004
433 INFECTION 51 0.0004
434 SCAB 4 0.0004
435 BRONCHOSPASM 5 0.0004
436 INTERNAL HAEMORRHAGE 4 0.0003
437 PRODUCT CONTAINER ISSUE 3 0.0003
438 CARDIAC OPERATION 3 0.0003
439 IMPAIRED QUALITY OF LIFE 5 0.0003
440 BLOOD MAGNESIUM DECREASED 3 0.0003
441 HYPERVENTILATION 2 0.0003
442 ANHEDONIA 9 0.0003
443 IMMUNOSUPPRESSION 3 0.0003
444 NECK PAIN 19 0.0003
445 LUNG INFILTRATION 3 0.0003
446 ATRIAL FIBRILLATION 33 0.0003
447 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
448 SKIN HAEMORRHAGE 5 0.0003
449 BLOOD IRON DECREASED 4 0.0003
450 PLEURISY 2 0.0003
451 EYE PAIN 19 0.0003
452 CARDIAC FAILURE CONGESTIVE 27 0.0003
453 ODYNOPHAGIA 2 0.0003
454 HYPERLIPIDAEMIA 4 0.0003
455 THROAT IRRITATION 15 0.0003
456 GASTROENTERITIS VIRAL 6 0.0003
457 TOOTHACHE 6 0.0003
458 INGUINAL HERNIA 2 0.0003
459 EATING DISORDER 7 0.0003
460 DEVICE FAILURE 5 0.0003
461 WEIGHT DECREASED 91 0.0003
462 DRUG ADMINISTRATION ERROR 10 0.0003
463 MENISCUS INJURY 2 0.0003
464 NERVE COMPRESSION 3 0.0003
465 SPINAL OPERATION 4 0.0003
466 THYROID DISORDER 5 0.0003
467 PRODUCT DISTRIBUTION ISSUE 3 0.0003
468 PHARYNGITIS 4 0.0003
469 PRE-EXISTING CONDITION IMPROVED 2 0.0003
470 FLANK PAIN 3 0.0003
471 NASAL DRYNESS 2 0.0003
472 PERIPHERAL SWELLING 49 0.0003
473 INTENTIONAL DOSE OMISSION 9 0.0003
474 TOOTH DISORDER 7 0.0003
475 LOWER LIMB FRACTURE 6 0.0003
476 TREATMENT NONCOMPLIANCE 17 0.0003
477 HYPERCHOLESTEROLAEMIA 3 0.0003
478 CARDIAC FLUTTER 2 0.0003
479 OSTEOARTHRITIS 13 0.0003
480 HEPATOMEGALY 3 0.0003
481 BODY TEMPERATURE DECREASED 3 0.0003
482 HAEMATOCRIT DECREASED 6 0.0003
483 BLOOD POTASSIUM DECREASED 9 0.0003
484 POST-TRAUMATIC STRESS DISORDER 2 0.0003
485 CELLULITIS 15 0.0003
486 EYE PRURITUS 10 0.0003
487 PRODUCT PHYSICAL ISSUE 6 0.0003
488 POSTOPERATIVE WOUND INFECTION 2 0.0003
489 SEPSIS 33 0.0003
490 FEEDING DISORDER 6 0.0003
491 DRY THROAT 3 0.0003
492 ACUTE KIDNEY INJURY 45 0.0003
493 IMPAIRED GASTRIC EMPTYING 4 0.0003
494 ABNORMAL LOSS OF WEIGHT 2 0.0003
495 ARTHRITIS 23 0.0003
496 FALL 97 0.0003
497 PERIPHERAL COLDNESS 4 0.0003
498 LYMPHOEDEMA 2 0.0003
499 ENCEPHALITIS 2 0.0003
500 DIVERTICULITIS 8 0.0003
501 SWELLING 27 0.0003
502 BACK PAIN 67 0.0003
503 LARGE INTESTINE PERFORATION 2 0.0003
504 DEFAECATION URGENCY 2 0.0003
505 INJECTION SITE DISCOMFORT 3 0.0003
506 BLOOD TEST ABNORMAL 4 0.0003
507 SCRATCH 3 0.0003
508 SKIN REACTION 4 0.0003
509 SLEEP DISORDER 20 0.0003
510 RENAL PAIN 3 0.0003
511 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
512 CYSTITIS 9 0.0003
513 VISUAL IMPAIRMENT 35 0.0003
514 HEAD DISCOMFORT 5 0.0003
515 DIVERTICULUM 2 0.0003
516 CHEST PAIN 52 0.0003
517 DRY EYE 14 0.0003
518 MOVEMENT DISORDER 9 0.0003
519 GALLBLADDER DISORDER 5 0.0003
520 THIRST 5 0.0003
521 HEREDITARY ANGIOEDEMA 3 0.0003
522 PLEURAL EFFUSION 17 0.0003
523 NIGHT SWEATS 9 0.0003
524 SKIN CANCER 6 0.0003
525 FAECES DISCOLOURED 6 0.0003
526 FAECES SOFT 2 0.0003
527 RESTLESS LEGS SYNDROME 5 0.0003
528 FLUID OVERLOAD 4 0.0003
529 BLOOD PRESSURE INCREASED 42 0.0003
530 PANIC ATTACK 10 0.0003
531 ASPIRATION 3 0.0003
532 GASTROOESOPHAGEAL REFLUX DISEASE 22 0.0003
533 HEART RATE INCREASED 27 0.0003
534 TOOTH FRACTURE 3 0.0003
535 ANAPHYLACTIC SHOCK 7 0.0003
536 PRODUCT USE ISSUE 51 0.0003
537 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
538 CEREBRAL DISORDER 2 0.0003
539 EXPOSURE VIA SKIN CONTACT 7 0.0003
540 VENTRICULAR FIBRILLATION 3 0.0003
541 ARTHROPOD BITE 2 0.0003
542 EYE SWELLING 10 0.0003
543 HEPATIC STEATOSIS 5 0.0003
544 BACTERIAL INFECTION 5 0.0003
545 HYDRONEPHROSIS 2 0.0003
546 THERAPY NON-RESPONDER 12 0.0003
547 OFF LABEL USE 232 0.0003
548 LACRIMATION INCREASED 8 0.0003
549 CORONARY ARTERY DISEASE 8 0.0003
550 POLLAKIURIA 11 0.0003
551 HEPATOCELLULAR CARCINOMA 2 0.0003
552 HERPES ZOSTER 15 0.0003
553 LIPASE INCREASED 2 0.0003
554 RESPIRATORY FAILURE 19 0.0003
555 DRUG PRESCRIBING ERROR 5 0.0003
556 PHARYNGEAL OEDEMA 4 0.0003
557 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
558 MUSCULOSKELETAL CHEST PAIN 4 0.0003
559 ANKLE FRACTURE 4 0.0003
560 CONCUSSION 2 0.0003
561 CARDIAC DISORDER 24 0.0003
562 HAEMORRHOIDS 5 0.0003
563 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
564 EPISTAXIS 19 0.0003
565 TREMOR 42 0.0003
566 OCULAR HYPERAEMIA 12 0.0003
567 BACTERAEMIA 3 0.0003
568 FEELING COLD 7 0.0003
569 ULCER 4 0.0003
570 MIGRAINE 24 0.0003
571 NERVOUSNESS 13 0.0002
572 HIP FRACTURE 8 0.0002
573 MYASTHENIA GRAVIS 2 0.0002
574 NOCTURIA 3 0.0002
575 PRESYNCOPE 6 0.0002
576 OEDEMA PERIPHERAL 30 0.0002
577 NO THERAPEUTIC RESPONSE 3 0.0002
578 POST PROCEDURAL INFECTION 2 0.0002
579 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
580 DYSURIA 9 0.0002
581 HYPERSOMNIA 7 0.0002
582 MUSCLE SPASTICITY 3 0.0002
583 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
584 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
585 TOOTH LOSS 5 0.0002
586 RENAL FAILURE 32 0.0002
587 HEADACHE 151 0.0002
588 EMBOLISM 2 0.0002
589 EXPIRED PRODUCT ADMINISTERED 8 0.0002
590 MUSCLE SPASMS 44 0.0002
591 DYSSTASIA 7 0.0002
592 GAIT INABILITY 8 0.0002
593 SKIN DISCOLOURATION 11 0.0002
594 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
595 ROAD TRAFFIC ACCIDENT 10 0.0002
596 WITHDRAWAL SYNDROME 10 0.0002
597 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
598 CARDIAC FAILURE 19 0.0002
599 URINARY INCONTINENCE 7 0.0002
600 DIABETES MELLITUS 18 0.0002
601 MALAISE 103 0.0002
602 FACIAL PARALYSIS 2 0.0002
603 ARTHROPATHY 13 0.0002
604 IRRITABLE BOWEL SYNDROME 5 0.0002
605 ANXIETY 66 0.0002
606 MYOPATHY 2 0.0002
607 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
608 AMNESIA 15 0.0002
609 DEAFNESS 6 0.0002
610 BLOOD CALCIUM INCREASED 2 0.0002
611 IMMUNE SYSTEM DISORDER 3 0.0002
612 GRIP STRENGTH DECREASED 2 0.0002
613 LIMB DISCOMFORT 7 0.0002
614 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
615 EYE HAEMORRHAGE 3 0.0002
616 GLOSSODYNIA 5 0.0002
617 GASTROINTESTINAL INFECTION 2 0.0002
618 ANAL INCONTINENCE 2 0.0002
619 BONE PAIN 13 0.0002
620 PRODUCT USE IN UNAPPROVED INDICATION 55 0.0002
621 CHILLS 26 0.0002
622 SURGERY 13 0.0002
623 HOSPITALISATION 34 0.0002
624 LEUKOCYTOSIS 4 0.0002
625 OSTEOMYELITIS 4 0.0002
626 NEUROPATHY PERIPHERAL 21 0.0002
627 TACHYPNOEA 3 0.0002
628 HYPOAESTHESIA 33 0.0002
629 PNEUMONITIS 6 0.0002
630 CONDITION AGGRAVATED 67 0.0002
631 ANAEMIA 42 0.0002
632 FATIGUE 170 0.0002
633 MENTAL STATUS CHANGES 6 0.0002
634 HUNGER 3 0.0002
635 WEIGHT INCREASED 48 0.0002
636 GAIT DISTURBANCE 41 0.0002
637 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 10 0.0002
638 DIARRHOEA HAEMORRHAGIC 2 0.0002
639 PAIN IN EXTREMITY 63 0.0002
640 BLISTER 12 0.0002
641 ASTHENIA 80 0.0002
642 PHOTOPHOBIA 4 0.0002
643 STAPHYLOCOCCAL INFECTION 7 0.0002
644 HYPOCALCAEMIA 4 0.0002
645 SINUS TACHYCARDIA 3 0.0002
646 INFUSION RELATED REACTION 14 0.0002
647 ABDOMINAL DISTENSION 22 0.0002
648 ECZEMA 11 0.0002
649 FEELING JITTERY 4 0.0002
650 RED BLOOD CELL COUNT DECREASED 6 0.0002
651 EYE INFLAMMATION 2 0.0002
652 FEELING ABNORMAL 50 0.0002
653 DEPRESSED MOOD 11 0.0002
654 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
655 HYPERTHYROIDISM 3 0.0002
656 MENTAL DISORDER 9 0.0002
657 DECREASED APPETITE 48 0.0002
658 HYPOKINESIA 3 0.0002
659 NEEDLE ISSUE 6 0.0002
660 LABORATORY TEST ABNORMAL 6 0.0002
661 HYPERTENSION 43 0.0002
662 OEDEMA 11 0.0002
663 DISABILITY 4 0.0002
664 INABILITY TO AFFORD MEDICATION 2 0.0002
665 HYPERSENSITIVITY 37 0.0002
666 HALLUCINATION 15 0.0002
667 THROMBOSIS 16 0.0002
668 PRODUCT ADMINISTRATION ERROR 4 0.0002
669 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
670 BLOOD COUNT ABNORMAL 3 0.0002
671 LYMPHADENOPATHY 7 0.0002
672 ABDOMINAL PAIN LOWER 5 0.0002
673 PRODUCT COMPLAINT 5 0.0002
674 ARTHRALGIA 82 0.0002
675 TASTE DISORDER 4 0.0002
676 PAIN 121 0.0002
677 MOTOR DYSFUNCTION 2 0.0002
678 HIP ARTHROPLASTY 3 0.0002
679 LOSS OF CONSCIOUSNESS 25 0.0002
680 INITIAL INSOMNIA 2 0.0002
681 LYMPHOMA 3 0.0002
682 MYALGIA 33 0.0002
683 FLATULENCE 11 0.0002
684 CARDIAC ARREST 16 0.0002
685 LUNG INFECTION 3 0.0002
686 EYE DISCHARGE 2 0.0002
687 BRAIN FOG 3 0.0002
688 TACHYCARDIA 17 0.0002
689 EYE IRRITATION 11 0.0002
690 CYANOSIS 3 0.0002
691 INCORRECT DOSE ADMINISTERED BY DEVICE 5 0.0002
692 PRODUCT USE COMPLAINT 3 0.0002
693 KNEE ARTHROPLASTY 4 0.0002
694 GASTROINTESTINAL DISORDER 17 0.0002
695 HALLUCINATION, VISUAL 4 0.0002
696 VISION BLURRED 26 0.0002
697 INCONTINENCE 2 0.0002
698 INSOMNIA 50 0.0002
699 RECTAL HAEMORRHAGE 8 0.0002
700 DRUG EFFECT DECREASED 10 0.0002
701 MUSCLE TIGHTNESS 3 0.0002
702 URTICARIA 31 0.0002
703 DRY MOUTH 15 0.0002
704 ABDOMINAL DISCOMFORT 31 0.0002
705 PHARYNGITIS STREPTOCOCCAL 2 0.0002
706 PRURITUS 71 0.0002
707 BIPOLAR DISORDER 2 0.0002
708 CONSTIPATION 40 0.0002
709 OESOPHAGITIS 2 0.0002
710 CEREBROVASCULAR ACCIDENT 31 0.0002
711 METASTASES TO BONE 3 0.0002
712 DRUG DOSE OMISSION 30 0.0002
713 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
714 BLOOD PRESSURE DECREASED 12 0.0002
715 DIZZINESS 90 0.0002
716 FOOT DEFORMITY 2 0.0002
717 COAGULOPATHY 3 0.0002
718 SKIN DISORDER 6 0.0002
719 PLASMA CELL MYELOMA 7 0.0002
720 BLOOD UREA INCREASED 3 0.0002
721 INJECTION SITE PRURITUS 12 0.0002
722 MALNUTRITION 2 0.0002
723 VOMITING 84 0.0002
724 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
725 UNDERDOSE 13 0.0002
726 HYPONATRAEMIA 10 0.0002
727 MITRAL VALVE INCOMPETENCE 2 0.0002
728 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
729 DEPRESSION 40 0.0002
730 HAEMOGLOBIN DECREASED 18 0.0002
731 HAEMATURIA 6 0.0002
732 GASTRIC DISORDER 6 0.0002
733 DIARRHOEA 112 0.0002
734 DELIRIUM 6 0.0002
735 DEHYDRATION 23 0.0002
736 ORTHOSTATIC HYPOTENSION 3 0.0002
737 HAEMORRHAGE 18 0.0002
738 POST PROCEDURAL HAEMORRHAGE 2 0.0002
739 SPEECH DISORDER 9 0.0002
740 INTENTIONAL OVERDOSE 11 0.0002
741 COGNITIVE DISORDER 8 0.0002
742 PALPITATIONS 20 0.0002
743 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
744 DYSPHAGIA 16 0.0002
745 RENAL INJURY 5 0.0002
746 ISCHAEMIC STROKE 3 0.0002
747 CONFUSIONAL STATE 27 0.0002
748 NAUSEA 132 0.0002
749 IRRITABILITY 10 0.0002
750 MYOCARDIAL INFARCTION 29 0.0002
751 DRUG EFFECT INCOMPLETE 6 0.0002
752 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
753 BURSITIS 2 0.0002
754 ADRENAL INSUFFICIENCY 2 0.0002
755 ACCIDENTAL OVERDOSE 6 0.0002
756 INJECTION SITE URTICARIA 4 0.0002
757 DYSPEPSIA 16 0.0002
758 CARDIOMEGALY 2 0.0002
759 BLOOD GLUCOSE ABNORMAL 3 0.0002
760 GENERALISED OEDEMA 2 0.0002
761 PANCYTOPENIA 9 0.0002
762 THINKING ABNORMAL 3 0.0002
763 ILEUS 2 0.0002
764 SEPTIC SHOCK 7 0.0002
765 INTESTINAL OBSTRUCTION 6 0.0002
766 BLOOD SODIUM DECREASED 3 0.0002
767 MUSCULAR WEAKNESS 18 0.0002
768 BLOOD URINE PRESENT 3 0.0002
769 MUSCLE ATROPHY 2 0.0002
770 MUSCULOSKELETAL DISORDER 3 0.0002
771 BURNING SENSATION 11 0.0002
772 HYPOTHYROIDISM 5 0.0002
773 HYPOPHAGIA 4 0.0002
774 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
775 DEATH 133 0.0002
776 EAR PAIN 3 0.0002
777 ORAL HERPES 3 0.0002
778 SKIN FISSURES 3 0.0002
779 NODULE 2 0.0002
780 MUSCULOSKELETAL PAIN 8 0.0002
781 CHOLELITHIASIS 5 0.0002
782 TINNITUS 7 0.0002
783 GASTRITIS 4 0.0002
784 DISORIENTATION 6 0.0002
785 ADVERSE REACTION 2 0.0002
786 ABDOMINAL PAIN UPPER 31 0.0002
787 PYREXIA 52 0.0002
788 BLOOD CHOLESTEROL INCREASED 7 0.0002
789 LIP SWELLING 5 0.0001
790 DRY SKIN 20 0.0001
791 RHEUMATOID ARTHRITIS 17 0.0001
792 MALIGNANT MELANOMA 2 0.0001
793 JOINT SWELLING 18 0.0001
794 DISTURBANCE IN ATTENTION 8 0.0001
795 ILL-DEFINED DISORDER 9 0.0001
796 PULMONARY EMBOLISM 14 0.0001
797 DEVICE MECHANICAL ISSUE 2 0.0001
798 SKIN LESION 4 0.0001
799 INFLUENZA LIKE ILLNESS 12 0.0001
800 UNEVALUABLE EVENT 11 0.0001
801 ANAPHYLACTIC REACTION 8 0.0001
802 HYPOTENSION 29 0.0001
803 SOMNOLENCE 29 0.0001
804 NEOPLASM PROGRESSION 5 0.0001
805 INJECTION SITE SWELLING 11 0.0001
806 DERMATITIS 3 0.0001
807 WOUND 4 0.0001
808 HYPERKALAEMIA 5 0.0001
809 DEVICE OCCLUSION 2 0.0001
810 LYMPHOPENIA 2 0.0001
811 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
812 PLATELET COUNT DECREASED 15 0.0001
813 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
814 EMOTIONAL DISTRESS 17 0.0001
815 PRODUCT ADHESION ISSUE 5 0.0001
816 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
817 PARAESTHESIA 22 0.0001
818 HYPERHIDROSIS 18 0.0001
819 BALANCE DISORDER 12 0.0001
820 PRURITUS GENERALISED 3 0.0001
821 PARAESTHESIA ORAL 2 0.0001
822 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
823 MEMORY IMPAIRMENT 19 0.0001
824 PRODUCT DISPENSING ERROR 3 0.0001
825 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
826 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
827 COLON CANCER 2 0.0001
828 RASH 58 0.0001
829 CHROMATURIA 3 0.0001
830 DRUG DISPENSING ERROR 2 0.0001
831 FEELING HOT 8 0.0001
832 MUSCLE TWITCHING 3 0.0001
833 SEIZURE 15 0.0001
834 DRUG INEFFECTIVE 171 0.0001
835 RASH PRURITIC 7 0.0001
836 DELUSION 2 0.0001
837 EJECTION FRACTION DECREASED 2 0.0001
838 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
839 BASAL CELL CARCINOMA 2 0.0001
840 INJURY 9 0.0001
841 BONE DENSITY DECREASED 4 0.0001
842 MEDICATION ERROR 7 0.0001
843 BLOOD PRESSURE FLUCTUATION 3 0.0001
844 DRUG INTOLERANCE 12 0.0001
845 DYSKINESIA 5 0.0001
846 BLINDNESS 5 0.0001
847 INCORRECT DOSE ADMINISTERED 28 0.0001
848 BLOOD CREATININE INCREASED 8 0.0001
849 ADVERSE DRUG REACTION 11 0.0001
850 MULTIPLE FRACTURES 2 0.0001
851 PRODUCT SUBSTITUTION ISSUE 7 0.0001
852 MANIA 2 0.0001
853 INJECTION SITE ERYTHEMA 15 0.0001
854 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
855 AGEUSIA 3 0.0001
856 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
857 HAEMATEMESIS 3 0.0001
858 FLUSHING 12 0.0001
859 HEPATITIS 3 0.0001
860 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
861 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
862 INFLAMMATION 6 0.0001
863 RASH GENERALISED 3 0.0001
864 THERAPEUTIC RESPONSE DECREASED 7 0.0001
865 DEVICE USE ERROR 4 0.0001
866 RASH MACULAR 4 0.0001
867 EOSINOPHILIA 2 0.0001
868 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
869 CEREBRAL HAEMORRHAGE 4 0.0001
870 FEAR 3 0.0001
871 THROAT TIGHTNESS 3 0.0001
872 BONE DISORDER 2 0.0001
873 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
874 ABNORMAL DREAMS 3 0.0001
875 HYPOKALAEMIA 5 0.0001
876 INJECTION SITE PAIN 33 0.0001
877 SWELLING FACE 7 0.0001
878 RENAL IMPAIRMENT 9 0.0001
879 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
880 HEPATIC CIRRHOSIS 2 0.0001
881 TARDIVE DYSKINESIA 3 0.0001
882 FRACTURE 2 0.0001
883 ARRHYTHMIA 5 0.0001
884 COLITIS 4 0.0001
885 GASTRIC ULCER 2 0.0001
886 ANGINA PECTORIS 3 0.0001
887 INCREASED APPETITE 2 0.0001
888 ERUCTATION 2 0.0001
889 MUSCULOSKELETAL STIFFNESS 9 0.0001
890 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
891 ACUTE MYOCARDIAL INFARCTION 3 0.0001
892 PSYCHOTIC DISORDER 3 0.0001
893 SYNCOPE 10 0.0001
894 STOMATITIS 6 0.0001
895 ABDOMINAL PAIN 23 0.0001
896 DEVICE BREAKAGE 4 0.0001
897 THROMBOCYTOPENIA 11 0.0001
898 BODY TEMPERATURE INCREASED 2 0.0001
899 THERAPY INTERRUPTED 7 0.0001
900 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
901 MOBILITY DECREASED 7 0.0001
902 MOUTH ULCERATION 2 0.0001
903 DERMATITIS ATOPIC 5 0.0001
904 SKIN EXFOLIATION 8 0.0001
905 PANCREATITIS 5 0.0001
906 DYSGEUSIA 7 0.0001
907 IMPAIRED WORK ABILITY 2 0.0001
908 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
909 DEVICE LEAKAGE 4 0.0001
910 VAGINAL HAEMORRHAGE 4 0.0001
911 IMPAIRED HEALING 3 0.0001
912 APPLICATION SITE PAIN 2 0.0001
913 HAEMATOCHEZIA 5 0.0001
914 NEOPLASM MALIGNANT 6 0.0001
915 APPLICATION SITE PRURITUS 2 0.0001
916 ERYTHEMA 18 0.0001
917 SUICIDAL IDEATION 8 0.0001
918 PROSTATE CANCER 7 0.0001
919 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
920 RENAL DISORDER 4 0.0001
921 DISEASE PROGRESSION 10 0.0001
922 DIABETIC KETOACIDOSIS 2 0.0001
923 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
924 HYPERGLYCAEMIA 3 0.0001
925 DISCOMFORT 5 0.0001
926 LIVER INJURY 2 0.0001
927 ALOPECIA 16 0.0001
928 INJECTION SITE MASS 3 0.0001
929 THERAPY CESSATION 4 0.0001
930 HAEMATOMA 2 0.0001
931 DIPLOPIA 2 0.0001
932 APPLICATION SITE ERYTHEMA 2 0.0001
933 ADVERSE EVENT 7 0.0001
934 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
935 BREAST CANCER FEMALE 2 0.0001
936 JAUNDICE 2 0.0001
937 PAIN OF SKIN 2 0.0001
938 BLOOD BILIRUBIN INCREASED 2 0.0001
939 PALLOR 2 0.0001
940 TREATMENT FAILURE 6 0.0001
941 PROCEDURAL PAIN 2 0.0001
942 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
943 SKIN BURNING SENSATION 5 0.0001
944 LETHARGY 4 0.0001
945 DEVICE DISLOCATION 3 0.0001
946 PRODUCT STORAGE ERROR 6 0.0001
947 ASCITES 2 0.0001
948 BLADDER CANCER 4 0.0001
949 ANGIOEDEMA 3 0.0001
950 APHASIA 2 0.0001
951 VERTIGO 4 0.0001
952 OVERDOSE 14 0.0001
953 BLOOD GLUCOSE INCREASED 12 0.0001
954 DISEASE RECURRENCE 3 0.0001
955 DRUG INTERACTION 10 0.0001
956 COMA 3 0.0001
957 RENAL CANCER 3 0.0001
958 RASH ERYTHEMATOUS 3 0.0001
959 METABOLIC ACIDOSIS 2 0.0001
960 HYPOGLYCAEMIA 3 0.0001
961 DEEP VEIN THROMBOSIS 4 0.0001
962 PSORIASIS 8 0.0001
963 DEVICE DIFFICULT TO USE 4 0.0001
964 AGGRESSION 3 0.0001
965 ANGER 2 0.0001
966 HEPATIC ENZYME INCREASED 4 0.0001
967 INJECTION SITE REACTION 4 0.0001
968 NIGHTMARE 2 0.0001
969 DRUG WITHDRAWAL SYNDROME 5 0.0001
970 HEART RATE DECREASED 2 0.0001
971 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
972 NO ADVERSE EVENT 10 0.0001
973 CRYING 2 0.0001
974 C-REACTIVE PROTEIN INCREASED 2 0.0001
975 BREAST CANCER 5 0.0001
976 DYSARTHRIA 2 0.0001
977 HOT FLUSH 4 0.0001
978 ABNORMAL BEHAVIOUR 2 0.0001
979 INJECTION SITE HAEMORRHAGE 4 0.0001
980 COLITIS ULCERATIVE 2 0.0000
981 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
982 BLOOD GLUCOSE DECREASED 2 0.0000
983 INTERSTITIAL LUNG DISEASE 2 0.0000
984 AGITATION 3 0.0000
985 LEUKOPENIA 2 0.0000
986 NEUTROPENIA 5 0.0000
987 EXPOSURE DURING PREGNANCY 2 0.0000
988 ACNE 2 0.0000
989 INJECTION SITE BRUISING 2 0.0000
990 DRUG ABUSE 2 0.0000
991 TOXICITY TO VARIOUS AGENTS 4 0.0000
992 DRUG DEPENDENCE 2 0.0000